Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1F | P30939 | 20/20 | 0.56 |
| ▸ | HTR1D | P28221 | 13/20 | 0.56 |
| ▸ | HTR1B | P28222 | 12/20 | 0.56 |
| ▸ | HTR1A | P08908 | 12/20 | 0.55 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 2/20 | 0.50 |
| ▸ | HTR1E | P28566 | 2/20 | 0.50 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.50 |
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8381566 | 0.82 | HTR1F (0.59) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| SCHEMBL8385396 | 0.82 | HTR1F (0.56) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| SCHEMBL8387305 | 0.80 | HTR1F (0.73) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| SCHEMBL8387190 | 0.80 | HTR1D (0.52) | HTR1FHTR1DHTR1BHTR1A | |
| SCHEMBL8383872 | 0.79 | HTR1F (0.72) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| Malonic Acid SCHEMBL8651902 | 0.78 | HTR1F (0.57) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| SCHEMBL8386417 | 0.77 | HTR1F (0.56) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| SCHEMBL8381458 | 0.77 | HTR1D (0.51) | HTR1FHTR1DHTR1BHTR1A | |
| SCHEMBL8383476 | 0.76 | HTR1F (0.56) | HTR1FHTR1DHTR1BHTR1AHTR2A | |
| Fumaric Acid SCHEMBL7013574 | 0.76 | HTR1F (0.56) | HTR1FHTR1DHTR1BHTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024073845-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | VALORISATION HSJ, LIMITED PARTNERSHIP (CA) | 2024-04-11 | — | — | WO | disclosed |
| US-5874427-A | MIGRAINE | ELI LILLY AND COMPANY (US) | 1999-02-23 | — | — | US | disclosed |